Abreu MT - Search Results

1

A pilot study of adalimumab in infliximab-allergic patients.

Youdim A, Vasiliauskas EA, Targan SR, Papadakis KA, Ippoliti A, Dubinsky MC, Lechago J, Paavola J, Loane J, Lee SK, Gaiennie J, Smith K, Do J, Abreu MT. Youdim A, et al. Among authors: abreu mt. Inflamm Bowel Dis. 2004 Jul;10(4):333-8. doi: 10.1097/00054725-200407000-00002. Inflamm Bowel Dis. 2004. PMID: 15475739 Clinical Trial.

2

Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.

Hassard PV, Vasiliauskas EA, Kam LY, Targan SR, Abreu MT. Hassard PV, et al. Among authors: abreu mt. Inflamm Bowel Dis. 2000 Feb;6(1):16-20. doi: 10.1097/00054725-200002000-00003. Inflamm Bowel Dis. 2000. PMID: 10701145

3

Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.

Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Papadakis KA, et al. Among authors: abreu mt. Am J Gastroenterol. 2001 Jul;96(7):2137-42. doi: 10.1111/j.1572-0241.2001.03949.x. Am J Gastroenterol. 2001. PMID: 11467645

4

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.

Dubinsky MC, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Among authors: abreu mt. Inflamm Bowel Dis. 2001 Aug;7(3):181-9. doi: 10.1097/00054725-200108000-00001. Inflamm Bowel Dis. 2001. PMID: 11515842 Clinical Trial.

5

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

Dubinsky MC, Yang H, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Among authors: abreu mt. Gastroenterology. 2002 Apr;122(4):904-15. doi: 10.1053/gast.2002.32420. Gastroenterology. 2002. PMID: 11910342 Clinical Trial.

6

Controversies in IBD. Serologic tests are helpful in managing inflammatory bowel disease.

Abreu MT. Abreu MT. Inflamm Bowel Dis. 2002 May;8(3):224-6; discussion 223, 230-1. doi: 10.1097/00054725-200205000-00012. Inflamm Bowel Dis. 2002. PMID: 11979146 No abstract available.

7

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.

Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, Vasiliauskas EA, Kam LY, Rojany M, Papadakis KA, Rotter JI, Targan SR, Yang H. Abreu MT, et al. Gastroenterology. 2002 Sep;123(3):679-88. doi: 10.1053/gast.2002.35393. Gastroenterology. 2002. PMID: 12198692

8

Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.

Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA. Dubinsky MC, et al. Among authors: abreu mt. Am J Gastroenterol. 2003 May;98(5):1058-63. doi: 10.1111/j.1572-0241.2003.07413.x. Am J Gastroenterol. 2003. PMID: 12809828

9

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients.

Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, Martin P, Vierling JM, Geller SA, Targan SR, Poordad FF. Dubinsky MC, et al. Among authors: abreu mt. Gastroenterology. 2003 Aug;125(2):298-303. doi: 10.1016/s0016-5085(03)00938-7. Gastroenterology. 2003. PMID: 12891528

10

Infliximab in the treatment of medically refractory indeterminate colitis.

Papadakis KA, Treyzon L, Abreu MT, Fleshner PR, Targan SR, Vasiliauskas EA. Papadakis KA, et al. Among authors: abreu mt. Aliment Pharmacol Ther. 2003 Oct 1;18(7):741-7. doi: 10.1046/j.1365-2036.2003.01739.x. Aliment Pharmacol Ther. 2003. PMID: 14510748 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters